FARA research grant will help evaluate potential of SBT-589
A newly awarded research grant from the Friedreich’s Ataxia Research Alliance (FARA) and FARA Ireland will help Stealth Biotherapeutics to evaluate the potential of its novel therapy SBT-589 for treating nerve damage in Friedreich’s ataxia (FA). The grant, the Kyle Bryant Translational Research Award — named for the…